Possesses a master’s degree in DMPK, with over 10 years of industrial experience in clinical pharmacology and pharmacometrics. Has participated in the research and development of multiple pharmaceutical products that have obtained marketing authorization from regulatory authorities including FDA, EMA and NMPA. Primary research interests focus on complex quantitative pharmacological models and the application of artificial intelligence in clinical drug development.